139 related articles for article (PubMed ID: 34958000)
1. Cytoplasmic expression of DCLK1-S, a novel DCLK1 isoform, is associated with tumor aggressiveness and worse disease-specific survival in colorectal cancer.
Kalantari E; Ghods R; Saeednejad Zanjani L; Rahimi M; Eini L; Razmi M; Asadi-Lari M; Madjd Z
Cancer Biomark; 2022; 33(3):277-289. PubMed ID: 34958000
[TBL] [Abstract][Full Text] [Related]
2. A novel antibody against cancer stem cell biomarker, DCLK1-S, is potentially useful for assessing colon cancer risk after screening colonoscopy.
Sarkar S; Popov VL; O'Connell MR; Stevenson HL; Lee BS; Obeid RA; Luthra GK; Singh P
Lab Invest; 2017 Oct; 97(10):1245-1261. PubMed ID: 28414327
[TBL] [Abstract][Full Text] [Related]
3. Role of doublecortin-like kinase 1 and leucine-rich repeat-containing G-protein-coupled receptor 5 in patients with stage II/III colorectal cancer: Cancer progression and prognosis.
Kang XL; He LR; Chen YL; Wang SB
World J Gastroenterol; 2020 Nov; 26(43):6853-6866. PubMed ID: 33268966
[TBL] [Abstract][Full Text] [Related]
4. Increased expression of DCLK1, a novel putative CSC maker, is associated with tumor aggressiveness and worse disease-specific survival in patients with bladder carcinomas.
Shafiei S; Kalantari E; Saeednejad Zanjani L; Abolhasani M; Asadi Lari MH; Madjd Z
Exp Mol Pathol; 2019 Jun; 108():164-172. PubMed ID: 31028726
[TBL] [Abstract][Full Text] [Related]
5. DCLK1 promotes colorectal cancer stemness and aggressiveness via the XRCC5/COX2 axis.
Kim JH; Park SY; Jeon SE; Choi JH; Lee CJ; Jang TY; Yun HJ; Lee Y; Kim P; Cho SH; Lee JS; Nam JS
Theranostics; 2022; 12(12):5258-5271. PubMed ID: 35910805
[No Abstract] [Full Text] [Related]
6. The Essential Role of DCLK1 in Pathogenesis, Diagnostic Procedures and Prognostic Stratification of Colorectal Cancer.
Gzil A; Szylberg Ł; Jaworski D; Dominiak J; Zarębska I; Grzanka D
Anticancer Res; 2019 Jun; 39(6):2689-2697. PubMed ID: 31177103
[TBL] [Abstract][Full Text] [Related]
7. Oncogenic functions and clinical significances of DCLK1 isoforms in colorectal cancer: a systematic review and meta-analysis.
Kalantari E; Razmi M; Tajik F; Asadi-Lari M; Ghods R; Madjd Z
Cancer Cell Int; 2022 Jun; 22(1):217. PubMed ID: 35717205
[TBL] [Abstract][Full Text] [Related]
8. DCLK1 is up-regulated and associated with metastasis and prognosis in colorectal cancer.
Gao T; Wang M; Xu L; Wen T; Liu J; An G
J Cancer Res Clin Oncol; 2016 Oct; 142(10):2131-40. PubMed ID: 27520310
[TBL] [Abstract][Full Text] [Related]
9. A new insight into cancer stem cell markers: Could local and circulating cancer stem cell markers correlate in colorectal cancer?
Mirzaei A; Tavoosidana G; Rad AA; Rezaei F; Tavakoli-Yaraki M; Kadijani AA; Khalili E; Madjd Z
Tumour Biol; 2016 Feb; 37(2):2405-14. PubMed ID: 26383518
[TBL] [Abstract][Full Text] [Related]
10. Targeting DCLK1 overcomes 5-fluorouracil resistance in colorectal cancer through inhibiting CCAR1/β-catenin pathway-mediated cancer stemness.
Wang L; Zhao L; Lin Z; Yu D; Jin M; Zhou P; Ren J; Cheng J; Yang K; Wu G; Zhang T; Zhang D
Clin Transl Med; 2022 May; 12(5):e743. PubMed ID: 35522902
[TBL] [Abstract][Full Text] [Related]
11. FOXD3 Regulates CSC Marker, DCLK1-S, and Invasive Potential: Prognostic Implications in Colon Cancer.
Sarkar S; O'Connell MR; Okugawa Y; Lee BS; Toiyama Y; Kusunoki M; Daboval RD; Goel A; Singh P
Mol Cancer Res; 2017 Dec; 15(12):1678-1691. PubMed ID: 28851816
[TBL] [Abstract][Full Text] [Related]
12. Application of RNA-sequencing to identify transcriptome modification by DCLK1 in colorectal cancer cells.
Li L; Mei H; Commey ANA
Cancer Gene Ther; 2020 Sep; 27(9):691-701. PubMed ID: 31636360
[TBL] [Abstract][Full Text] [Related]
13. DCLK1, a promising colorectal cancer stem cell marker, regulates tumor progression and invasion through miR-137 and miR-15a dependent manner.
Razi S; Sadeghi A; Asadi-Lari Z; Tam KJ; Kalantari E; Madjd Z
Clin Exp Med; 2021 Feb; 21(1):139-147. PubMed ID: 32965580
[TBL] [Abstract][Full Text] [Related]
14. DCLK1 plays an important role in colorectal cancer tumorgenesis through the regulation of miR-200c.
Mohammadi Y; Tavangar SM; Saidijam M; Amini R; Etemadi K; Karimi Dermani F; Najafi R
Biomed Pharmacother; 2018 Jul; 103():301-307. PubMed ID: 29656186
[TBL] [Abstract][Full Text] [Related]
15. Induction of let-7e gene expression attenuates oncogenic phenotype in HCT-116 colorectal cancer cells through targeting of DCLK1 regulation.
Khodadadi Kohlan A; Saidijam M; Amini R; Samadi P; Najafi R
Life Sci; 2019 Jul; 228():221-227. PubMed ID: 31075231
[TBL] [Abstract][Full Text] [Related]
16. Enhancement of Sensitivity to Chemo/Radiation Therapy by Using miR-15b against DCLK1 in Colorectal Cancer.
Ji D; Zhan T; Li M; Yao Y; Jia J; Yi H; Qiao M; Xia J; Zhang Z; Ding H; Song C; Han Y; Gu J
Stem Cell Reports; 2018 Dec; 11(6):1506-1522. PubMed ID: 30449704
[TBL] [Abstract][Full Text] [Related]
17. Upregulation of circulating cancer stem cell marker, DCLK1 but not Lgr5, in chemoradiotherapy-treated colorectal cancer patients.
Mirzaei A; Tavoosidana G; Modarressi MH; Rad AA; Fazeli MS; Shirkoohi R; Tavakoli-Yaraki M; Madjd Z
Tumour Biol; 2015 Jun; 36(6):4801-10. PubMed ID: 25631749
[TBL] [Abstract][Full Text] [Related]
18. DCLK1 Expression in Colorectal Polyps Increases with the Severity of Dysplasia.
Takiyama A; Tanaka T; Kazama S; Nagata H; Kawai K; Hata K; Otani K; Nishikawa T; Sasaki K; Kaneko M; Emoto S; Murono K; Takiyama H; Nozawa H
In Vivo; 2018; 32(2):365-371. PubMed ID: 29475922
[TBL] [Abstract][Full Text] [Related]
19. Small molecule kinase inhibitor LRRK2-IN-1 demonstrates potent activity against colorectal and pancreatic cancer through inhibition of doublecortin-like kinase 1.
Weygant N; Qu D; Berry WL; May R; Chandrakesan P; Owen DB; Sureban SM; Ali N; Janknecht R; Houchen CW
Mol Cancer; 2014 May; 13():103. PubMed ID: 24885928
[TBL] [Abstract][Full Text] [Related]
20. DCLK1 integrates induction of TRIB3, EMT, drug resistance and poor prognosis in colorectal cancer.
Makino S; Takahashi H; Okuzaki D; Miyoshi N; Haraguchi N; Hata T; Matsuda C; Yamamoto H; Mizushima T; Mori M; Doki Y
Carcinogenesis; 2020 May; 41(3):303-312. PubMed ID: 31562741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
